Shah, A. Y., Escudier, B., Powles, T., Bourlon, M. T., Suarez, C., Porta, C., George, S., Choueiri, T. K., Motzer, R. J., Zhang, J., Williamson, D. S., Andrianova, L., Perez, J. R., Hall, T. D., Apolo, A. B. (2026). Cabozantinib plus nivolumab (C+N) versus sunitinib (S) in patients with advanced renal cell carcinoma (aRCC) and liver metastasis: Subgroup analysis of the phase 3 CheckMate-9ER trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4530